Form 8-K

U.S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): April 20, 2004

 


 

AMEDISYS, INC.

(Exact Name of Registrant as Specified in Charter)

 


 

Delaware

(State or Other Jurisdiction of

Incorporation or Organization)

 

0-24260   11-3131700
(Commission File Number)   (I.R.S. Employer Identification No.)

 

11100 Mead Road, Suite 300, Baton Rouge, LA 70816

(Address of principal executive offices including zip code)

 

(225) 292-2031

(Registrant’s telephone number, including area code)

 



ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS

 

(a)

  

Financial Statements of Business Acquired.

    

Not applicable.

(b)

  

Pro Forma Financial Information.

    

Not applicable.

(c)   

Exhibit
    No.


        Page

     99.1 (i)    Press Release dated April 20, 2004 announcing that the Company will release first quarter operating results on May 4, 2004 and host a conference call at 10:00 a.m. ET that same day    A-1

 

 

 

 


(i) Filed herewith.

 

ITEM 9. REGULATION FD DISCLOSURE

 

On April 20, 2004, Amedisys, Inc., “the Company”, issued a press release attached hereto as Exhibit 99.1 to announce that it will release first quarter operating results on May 4, 2004 and host a conference call at 10:00 a.m. ET that same day.


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

AMEDISYS, INC.

By:

 

/s/ Gregory H. Browne


   

Gregory H. Browne

   

Chief Financial Officer

 

DATE: April 27, 2004